Pre-Launch Opportunity Assessment

Manish Kumar

Associate Consultant

Nagarjun S

Senior Business Analyst

Client: BioPharma
Year: 2016

Pre-launch Opportunity assessment for any organization has become extremely important as it helps to understand the competitive landscape within the market, target patient segment etc., Especially for conditions like Cancer where there are so many developments going on for newer and effective treatments, it becomes very important for any organization to understand the penetration of current drugs within the market across different patient segments which in turn can help them develop robust strategies for the pipeline asset. To identify these opportunities, Pharma companies need strong and novel analytics approach to understand patient-level data and further understand how the treatment is distributed across different patient segments

Frequently, these analyses require extensive use of real-world patient level claims and EHR/EMR data sets and building robust metrics out of them. The biggest challenge is to handle unstructured EMR and claims data which makes it very difficult to identify and define key KPIs. We leveraged our knowledge of these datasets along with an analytical approach to develop an advanced algorithm to first clean the unstructured data and then define the treatment regimens and line of therapies to build the key KPI’s and extract insights with respect to patient segmentation and classification. The rich insights built from the data have helped multiple pharmaceutical customers to:

  1. To understand the detailed classification of patients for key metrics like regimen patient share across lines of therapy, regimen change, median duration of treatment, treatment break etc.,
  2. The classification further helped customers to create patient flow to develop a better understanding of patient segments and penetration of various drugs within the market which in turn helped them to develop a strategy for pipeline assets

Request a demo to find out how D Cube can help you to assess the opportunity for your upcoming drug and develop strategies that enable success in the market

ABOUT D CUBE

D Cube Analytics is an Integrated Data Sciences company focused on extracting transformational insights from syndicated, real world and digital data to increase revenue realization, avert revenue loss, enhance internal productivity and improve end user experience for global Pharmaceutical organizations.

D Cube is pioneering a Digital Transformation wave within BioPharma by leveraging new age tools and methodologies like Artificial Intelligence, Machine Learning and Robotic Process Automation to greatly improve the productivity of workforce and significantly enhancing speed to insight. Through this new age product-based approach to delivering analytics, we greatly reduce the cost and complexity of deployments and provide measurable value across multiple business functions.

Find out how D Cube can help you to elevate your market access intelligence and develop rigorous strategies that enable success in the market, throughout the product life cycle.

EXPERIENCE DDS SUITE

Reach out to us at info@dcubeanalytics.com for information and questions.